Onconic Therapeutics Inc. (KOSDAQ:476060)
16,210
+440 (2.79%)
Nov 20, 2025, 3:30 PM KST
Onconic Therapeutics Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 46,650 | 43,000 | 30,100 | 27,316 | 18,861 |
Cash & Short-Term Investments | 53,587 | 43,000 | 30,100 | 27,316 | 18,861 |
Cash Growth | 118.58% | 42.85% | 10.19% | 44.83% | - |
Accounts Receivable | 8,703 | 7,326 | -0 | 841.52 | 173.71 |
Other Receivables | 309.19 | 254.84 | 366.74 | 5.08 | 2.9 |
Receivables | 9,012 | 7,581 | 366.74 | 846.6 | 176.61 |
Other Current Assets | 2,793 | 1,554 | 291.85 | 8.22 | 10.43 |
Total Current Assets | 65,425 | 52,134 | 30,759 | 28,171 | 19,048 |
Property, Plant & Equipment | 3,093 | 3,285 | 3,568 | 2,619 | 263.6 |
Other Intangible Assets | 0.39 | 1.27 | 2.45 | 3.63 | 4.8 |
Long-Term Deferred Tax Assets | 5,355 | 5,355 | 3,100 | - | - |
Other Long-Term Assets | 7.35 | 137.95 | 118.38 | 113.14 | 110.6 |
Total Assets | 73,881 | 60,913 | 37,548 | 30,907 | 19,427 |
Accounts Payable | 2,649 | 708.67 | - | - | - |
Accrued Expenses | 89.15 | 65.56 | 82.14 | - | - |
Current Portion of Leases | 123.96 | 188.95 | 154.27 | 50.72 | 135.52 |
Current Income Taxes Payable | 22.39 | 463.39 | - | - | - |
Other Current Liabilities | 2,067 | 3,339 | 42,977 | 26,539 | 392.14 |
Total Current Liabilities | 4,951 | 4,765 | 43,214 | 26,590 | 527.66 |
Long-Term Leases | 48.41 | 119.52 | 199.4 | - | 53.52 |
Pension & Post-Retirement Benefits | - | 9.59 | 3.8 | 25.04 | - |
Other Long-Term Liabilities | 0 | 0 | 25.14 | 26,229 | 26,823 |
Total Liabilities | 5,000 | 4,895 | 43,442 | 52,844 | 27,405 |
Common Stock | 5,556 | 5,402 | 2,890 | 2,890 | 2,890 |
Additional Paid-In Capital | 39,287 | 87,419 | 7,146 | 7,146 | 7,146 |
Retained Earnings | 22,023 | -39,121 | -31,019 | -32,688 | -18,256 |
Comprehensive Income & Other | 2,016 | 2,319 | 1,294 | 715.69 | 243.21 |
Total Common Equity | 68,881 | 56,019 | -19,690 | -21,937 | -7,978 |
Shareholders' Equity | 68,881 | 56,019 | -5,894 | -21,937 | -7,978 |
Total Liabilities & Equity | 73,881 | 60,913 | 37,548 | 30,907 | 19,427 |
Total Debt | 172.37 | 308.47 | 353.66 | 50.72 | 189.04 |
Net Cash (Debt) | 53,414 | 42,691 | 29,747 | 27,265 | 18,672 |
Net Cash Growth | 121.06% | 43.52% | 9.10% | 46.02% | - |
Net Cash Per Share | - | 1305.39 | 12867.00 | 1179.32 | 815.23 |
Filing Date Shares Outstanding | - | 43.22 | 36.83 | 23.12 | 22.9 |
Total Common Shares Outstanding | - | 43.22 | 36.83 | 23.12 | 22.9 |
Working Capital | 60,474 | 47,369 | -12,454 | 1,581 | 18,520 |
Book Value Per Share | - | 1296.26 | -534.61 | -948.83 | -348.30 |
Tangible Book Value | 68,881 | 56,018 | -19,692 | -21,941 | -7,982 |
Tangible Book Value Per Share | - | 1296.23 | -534.68 | -948.99 | -348.51 |
Land | 570.58 | 570.58 | 570.58 | - | - |
Buildings | 1,617 | 1,617 | 1,617 | - | - |
Machinery | 1,375 | 1,138 | 1,033 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.